Table 1.
Intensity score of β-ARs in AS, LMS and LPS tissue specimens by IHC.
| Histology | N. cases | Patients | Original location | Grade | β1-AR | β2-AR | β3-AR |
|---|---|---|---|---|---|---|---|
| Angiosarcoma | 1 | 1 | Scalp | Primitive | ++ | +++ | – |
| Leiomyosarcoma | 5 | 1 | Jejunum | Metastasis | + | +++ | – |
| 2 | Uterus | Primitive | ++ | +++ | – | ||
| 3 | Skin | Primitive | + | +++ | – | ||
| 4 | Pelvis | Relapse | + | +++ | – | ||
| 5 | Skin | Metastasis | ++ | +++ | – | ||
| Dedifferentiated liposarcoma | 3 | 1 | Retroperitoneal | Primitive | ++ | +++ | – |
| 2 | Thigh | Relapse | + | +++ | – | ||
| 3 | Breast | Primitive | ++ | +++ | – | ||
| Atypical lipomatous tumor | 1 | 1 | Retroperitoneal | Primitive | + | +++ | – |
| Myxoid liposarcoma | 1 | 1 | Retroperitoneal | Primitive | ++ | +++ | – |
The quantification of β-AR expression in AS, LMS and LPS tissue specimens was evaluated using the following criteria: – undetectable staining; + weak; ++ moderate; +++ strong.